Molecular characteristics of non-small cell lung cancer tissue based on quantitative indicators of progesterone receptors expression

QR Code

Molecular characteristics of non-small cell lung cancer tissue based on quantitative indicators of progesterone receptors expression

Background. Progesterone receptors (PR) are regulators of cell proliferation and therefore can be considered as an aim for targeted medications in the treatment of oncological diseases. At the same time, a quantitative assessment of PR expression in the tissue of non-small cell lung cancer (NSCLC),...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. P. Romanov, T. A. Bogush, A. M. Scherbakov, A. A. Alimov, E. A. Bogush, A. B. Ravcheeva, A. Lee, V. S. Kosorukov
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2024-04-01
Series:	Антибиотики и Химиотерапия
Subjects:	progesterone receptors non-small cell lung cancer flow cytometry steroid receptor modulators
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1106
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation of quantitative measures of estrogen receptor α and β expression in non-small cell lung cancer tissue with clinical characteristics of the disease
by: T. A. Bogush, et al.
Published: (2021-08-01)

Progesterone and progesterone receptors in breast cancer: past, present, and future
by: M. V. Rodionova, et al.
Published: (2025-03-01)

IMMUNOREGULATION OF BLOOD SERUM ESTRADIOL AND PROGESTERONE LEVELS IN POSTMENOPAUSAL WOMEN
by: A. N. Glushkov, et al.
Published: (2019-12-01)

Endometrial expression of leukemia inhibitory factor in women with different estrogen/progesterone receptor status of the endometrium
by: S. S. Aganezov, et al.
Published: (2019-07-01)

Molecular mechanisms of resistance of endometrial hyperplasia to progestogen therapy based on the study of the expression of estrogen and progesterone receptors and paracrine cellular markers of cellular interaction
by: D.A. Khaskhachikh, et al.
Published: (2022-12-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
by: T. A. Bogush, et al.
Published: (2023-07-01)

Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2023-09-01)

Associations of antibodies to benzo[a]pyrene, estradiol and progesterone with estrogen receptor phenotype in breast cancer tissue
by: E. G. Polenok, et al.
Published: (2022-03-01)

CLINICAL AND HISTOLOGIC FEATURES OF UTERINE MYOMA IN REPRODUCTIVE-AGE WOMEN UNDER THE TREATMENT BY SELECTIVE PROGESTERONE RECEPTOR MODULATORS
by: I. O. Marinkin, et al.
Published: (2020-03-01)

Characterization of Non-Small Cell Lung Cancer Tissue by Quantitative Assessment of Class III β-Tubulin Expression
by: A. Lee, et al.
Published: (2024-10-01)

Estrogen and progesterone receptors expression in uveal melanoma tumor cells
by: S. V. Saakyan, et al.
Published: (2018-10-01)

Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation
by: Tatiana A. Fedotcheva, et al.
Published: (2025-06-01)

Synergistic action of steroid hormones and hormone-specific autoantibodies in breast cancer progression
by: A. N. Glushkov, et al.
Published: (2023-06-01)

Late Breast Cancer Recurrence Prediction: The Role of CTS5 and Progesterone Receptor Status
by: Carvalho GS, et al.
Published: (2025-07-01)

Expression of Estrogen Receptors β and ß<sub>1</sub> in Tissue of Human Non-Small Cell Lung Cancer
by: A. S. Shaturova, et al.
Published: (2020-05-01)

Abnormal expression of Hippo–YAP1 signalling pathway and progesterone resistance mechanism in endometrial polyps
by: Xinyu Yu, et al.
Published: (2025-12-01)

Characteristics of endometrial receptivity in women with different endometrial thickness
by: N. V. Aganezova, et al.
Published: (2022-05-01)

Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
by: Hamid Rezvani, et al.
Published: (2025-07-01)

Obesity and breast cancer
by: A. I. Berishvili, et al.
Published: (2022-12-01)

Influence of induced diabetes mellitus on hormonal profile of Lewis lung carcinoma in BALB/c Nude mice
by: E. M. Frantsiyants, et al.
Published: (2023-03-01)

FEATURES OF LOCAL AND SYSTEMIC IMMUNITY, AND MORPHO-FUNCTIONAL STATE OF ENDOMETRIUM IN WOMEN WITH ANOVULATORY SYNDROME
by: E. A. Michnina, et al.
Published: (2014-07-01)

INTERRELATION OF STEROID RECEPTOR GENE EXPRESSION IN UTERINE TISSUES AND SERUM CONCENTRATIONS OF IMMUNOREGULATORY PROTEINS, CYTOKINES, SEX STEROIDS IN PROLIFERATIVE DISEASES
by: S. V. Shramko, et al.
Published: (2018-11-01)

Association between glucocorticoid receptor beta and steroid resistance: A systematic review
by: Md. Mojahidur Hasan, et al.
Published: (2024-01-01)

Anti-idiotypic antibodies specific to steroid hormones and proliferative activity of tumor in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2024-11-01)

Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?
by: O. O. Gordeeva, et al.
Published: (2019-04-01)

Immunoassayofantibodies to benzo[a]pyrene, estradiol and progesterone fordeterminationofpersonal lung cancer riskinmen
by: A. N. Glushkov, et al.
Published: (2019-04-01)

[Immunohistochemical characteristic of myoma tissue in patients with uterine leiomyoma after treatment with ulipristal acetate]
by: Kuryk E.G., et al.
Published: (2015-09-01)

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy
by: A. I. Stukan, et al.
Published: (2022-12-01)

ANTIBODIES TO BENZO[A]PYRENE, ESTRADIOL AND PROGESTERONE AND GENE POLYMORPHISMS OF CYTOKINES: ASSOCIATIONS WITH LUNG CANCER IN MEN
by: A. N. Glushkov, et al.
Published: (2018-03-01)

Estrogen Receptor Expression in Tumors Different from Breast Cancer
by: T. A. Bogush, et al.
Published: (2020-05-01)

Antiidiotypic antibodies to estradiol and gene polymorphisms of α and β estrogenic receptors in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2024-01-01)

Modern aspects of complex treatment of hysteromyoma
by: L. V. Adamyan, et al.
Published: (2021-06-01)

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
by: Yu. S. Krumin, et al.
Published: (2021-03-01)

Mineralocorticoid receptor overactivation-induced remodeling of obese adipose tissue
by: WEN Runzhi, WANG Li, ZHAO Naiqian
Published: (2025-06-01)

THE PATHOGENETIC BASIS FOR USING NATURAL PROGESTERONE THERAPY IN OBSTETRIC PRACTICE
by: V. O. Bitsadze, et al.
Published: (2016-06-01)

Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications
by: Nagaraju Bandaru, et al.
Published: (2025-05-01)

Functional features of natural killer cells in acute myeloid leukemia
by: K. A. Nikiforova, et al.
Published: (2023-12-01)

Current aspects of systematics, diagnosis and treatment of breast cancer
by: D. N. Strunkin, et al.
Published: (2022-05-01)

Expression of steroid hormones receptors and morphofunctional condition endometrium at patients with anomalous uterine bleedings
by: I. P. Tayukina, et al.
Published: (2009-04-01)

The Quantitative Indices of ERCC1 Expression in Serous Ovarian Cancer Tissue and the Efficacy of First-Line Platinum-Based Chemotherapy
by: T. A. Bogush, et al.
Published: (2020-05-01)